Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Peripheral Blood Cell-Stratified Subgroups of Inflamed Depression.

Lynall ME, Turner L, Bhatti J, Cavanagh J, de Boer P, Mondelli V, Jones D, Drevets WC, Cowen P, Harrison NA, Pariante CM, Pointon L, Clatworthy MR, Bullmore E; Neuroimmunology of Mood Disorders and Alzheimer’s Disease (NIMA) Consortium.

Biol Psychiatry. 2019 Dec 2. pii: S0006-3223(19)31886-4. doi: 10.1016/j.biopsych.2019.11.017. [Epub ahead of print]

PMID:
32000983
2.

Childhood trauma, HPA axis activity and antidepressant response in patients with depression.

Nikkheslat N, McLaughlin AP, Hastings C, Zajkowska Z, Nettis MA, Mariani N, Enache D, Lombardo G, Pointon L, Cowen PJ, Cavanagh J, Harrison NA, Bullmore ET; NIMA Consortium, Pariante CM, Mondelli V.

Brain Behav Immun. 2019 Nov 30. pii: S0889-1591(19)30702-0. doi: 10.1016/j.bbi.2019.11.024. [Epub ahead of print]

3.

Diagnosis of concomitant inducible laryngeal obstruction and asthma.

Lee JW, Tay TR, Paddle P, Richards AL, Pointon L, Voortman M, Abramson MJ, Hoy R, Hew M.

Clin Exp Allergy. 2018 Dec;48(12):1622-1630. doi: 10.1111/cea.13185. Epub 2018 Jun 27.

PMID:
29870077
4.

Treatment-resistant depression and peripheral C-reactive protein.

Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET.

Br J Psychiatry. 2019 Jan;214(1):11-19. doi: 10.1192/bjp.2018.66. Epub 2018 May 16.

5.

Evaluation of Erytra® fully automated analyser for Routine Use in Transfusion Laboratory.

Chang C, Brown M, Davies L, Pointon L, Brown R, Barker D.

Transfus Med. 2014 Feb;24(1):33-8. doi: 10.1111/tme.12073. Epub 2013 Nov 5.

PMID:
24188135
6.

Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities.

Poole T, Goodyear-Smith F, Petousis-Harris H, Desmond N, Exeter D, Pointon L, Jayasinha R.

Vaccine. 2012 Dec 17;31(1):84-8. doi: 10.1016/j.vaccine.2012.10.099. Epub 2012 Nov 8.

PMID:
23142131
7.

Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study.

Hutton J, Walker LG, Gilbert FJ, Evans DG, Eeles R, Kwan-Lim GE, Thompson D, Pointon LJ, Sharp DM, Leach MO; UK Study Group for MRI Screening in Women at High Risk Study.

Br J Cancer. 2011 Feb 15;104(4):578-86. doi: 10.1038/bjc.2011.1.

8.

Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.

Evans DG, Lennard F, Pointon LJ, Ramus SJ, Gayther SA, Sodha N, Kwan-Lim GE, Leach MO, Warren R, Thompson D, Easton DF, Eeles R; UK Study of MRI Screening for Breast Cancer in Women at High Risk (MARIBS).

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2123-31. doi: 10.1158/1055-9965.EPI-09-0138. Epub 2009 Jun 30.

9.

A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging.

Khazen M, Warren RM, Boggis CR, Bryant EC, Reed S, Warsi I, Pointon LJ, Kwan-Lim GE, Thompson D, Eeles R, Easton D, Evans DG, Leach MO; Collaborators in the United Kingdom Medical Research Council Magnetic Resonance Imaging in Breast Screening (MARIBS) Study.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2268-74. doi: 10.1158/1055-9965.EPI-07-2547.

10.

BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials.

Tilanus-Linthorst MM, Obdeijn IM, Hop WC, Causer PA, Leach MO, Warner E, Pointon L, Hill K, Klijn JG, Warren RM, Gilbert FJ.

Clin Cancer Res. 2007 Dec 15;13(24):7357-62.

11.

Multiscale analysis of MR-mammography data.

Lessmann B, Nattkemper TW, Kessar P, Pointon L, Khazen M, Leach MO, Degenhard A.

Z Med Phys. 2007;17(3):166-71.

PMID:
17879813
12.

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.

Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Potterton J, Thompson D, Turnbull LW, Walker LG, Warren R, Leach MO; UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group.

Br J Cancer. 2006 Oct 9;95(7):801-10.

13.

A test of performance of breast MRI interpretation in a multicentre screening study.

Warren R, Hayes C, Pointon L, Hoff R, Gilbert FJ, Padhani AR, Rubin C, Kaplan G, Raza K, Wilkinson L, Hall-Craggs M, Kessar P, Rankin S, Dixon AK, Walsh J, Turnbull L, Britton P, Sinnatamby R, Easton D, Thompson D, Lakhani SR, Leach MO; UK MRC study of MRI screening for breast cancer in women at high risk (MARIBS).

Magn Reson Imaging. 2006 Sep;24(7):917-29. Epub 2006 May 23.

PMID:
16916709
14.

Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening study.

Warren RM, Thompson D, Pointon LJ, Hoff R, Gilbert FJ, Padhani AR, Easton DF, Lakhani SR, Leach MO; Collaborators in the United Kingdom Medical Research Council Magnetic Resonance Imaging in Breast Screening (MARIBS) Study.

Radiology. 2006 Jun;239(3):677-85.

PMID:
16714457
15.

Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis.

Warren RM, Pointon L, Thompson D, Hoff R, Gilbert FJ, Padhani A, Easton D, Lakhani SR, Leach MO; UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group.

Radiology. 2005 Sep;236(3):779-88.

PMID:
16118160
16.

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Thompson D, Warren RM; MARIBS study group.

Lancet. 2005 May 21-27;365(9473):1769-78. Erratum in: Lancet. 2005 May 28-Jun 3;365(9474):1848.

PMID:
15910949
17.

Evaluation of radiological features for breast tumour classification in clinical screening with machine learning methods.

Nattkemper TW, Arnrich B, Lichte O, Timm W, Degenhard A, Pointon L, Hayes C, Leach MO; UK MARIBS Breast Screening Study.

Artif Intell Med. 2005 Jun;34(2):129-39. Epub 2004 Dec 16.

PMID:
15894177
18.

Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer.

Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W; UK MRI Breast Screening Study Advisory Group.

Breast. 2000 Apr;9(2):78-82.

PMID:
14731703
19.

Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer.

Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W; UK MRI Breast Screening Study Advisory Group.

Breast. 2000 Apr;9(2):72-7.

PMID:
14731702
20.

The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS).

Leach MO, Eeles RA, Turnbull LW, Dixon AK, Brown J, Hoff RJ, Coulthard A, Dixon JM, Easton DF, Evans DG, Gilbert FJ, Hawnaur J, Hayes C, Kessar P, Lakhani S, Liney G, Moss SM, Padhani AP, Pointon LJ, Sydenham M, Walker LG, Warren RM, Haites NE, Morrison P, Cole T, Rayter Z, Donaldson A, Shere M, Rankin J, Goudie D, Steel CM, Davidson R, Chu C, Ellis I, Mackay J, Hodgson SV, Homfray T, Douglas F, Quarrell OW, Eccles DM, Gilbert FG, Crothers G, Walker CP, Jones A, Slack N, Britton P, Sheppard DG, Walsh J, Whitehouse G, Teh W, Rankin S, Boggis C, Potterton J, McLean L, Gordon PA, Rubin C; Magnetic Resonance Imaging as a Method of Screening for Breast Cancer Advisory Group.

J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):107-14.

PMID:
12585664
21.

What is the recall rate of breast MRI when used for screening asymptomatic women at high risk?

Warren RM, Pointon L, Caines R, Hayes C, Thompson D, Leach MO; UK MRI breast screening study (MARIBS).

Magn Reson Imaging. 2002 Sep;20(7):557-65.

PMID:
12413602
22.

Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

Brown J, Buckley D, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Graves M, Hayes C, Jenkins JP, Jones AP, Keevil SF, Leach MO, Liney GP, Moss SM, Padhani AR, Parker GJ, Pointon LJ, Ponder BA, Redpath TW, Sloane JP, Turnbull LW, Walker LG, Warren RM.

Magn Reson Imaging. 2000 Sep;18(7):765-76.

PMID:
11027869
23.

Co-morbidity in patients with abdominal aortic aneurysm.

Kanagasabay R, Gajraj H, Pointon L, Scott RA.

J Med Screen. 1996;3(4):208-10.

PMID:
9041487

Supplemental Content

Loading ...
Support Center